Reflux Co — SEC Form D Filing

Reflux Co filed an SEC Form D on May 22, 2026, reporting $525K raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
May 22, 2026
Amount reported
$525K
Industry
Health Care
Website
https://www.refluxcompany.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: WASHINGTON

Problem

Reflux diseases affect millions of people in the U.S., with current challenges in diagnosing atypical symptoms and treatment responsiveness.

Solution

The Reflux Company provides products like the real-time pH sensor Dx-pH System that functions in non-liquid environments and PepsinCheck for non-invasive diagnosis through saliva analysis.

Why now

There is a growing awareness and need for effective reflux solutions among patients and clinicians.

Verdict

Investors leaned in because the healthcare focus on reflux diseases appeared timely, not because the innovation was uniquely compelling. The implicit bet was on capturing a growing demand for more effective diagnostics, particularly in a market plagued by vague symptoms and ineffective treatments. However, the limited upside stems from the challenge of differentiation in a crowded health-tech space, where many solutions are vying for attention but few deliver an extraordinary edge.

Source: SEC EDGAR Form D filing